Charles M. Baum
2014
In 2014, Charles M. Baum earned a total compensation of $3M as President and Chief Executive Officer at Mirati Therapeutics, a 28% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $154,500 |
|---|---|
| Option Awards | $2,288,484 |
| Salary | $534,116 |
| Other | $78 |
| Total | $2,977,100 |
Baum received $2.3M in option awards, accounting for 77% of the total pay in 2014.
Baum also received $154.5K in non-equity incentive plan, $534.1K in salary and $78 in other compensation.
Rankings
In 2014, Charles M. Baum's compensation ranked 3,053rd out of 13,032 executives tracked by ExecPay. In other words, Baum earned more than 76.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,053 out of 13,032 | 77th |
Division Manufacturing | 1,082 out of 4,966 | 78th |
Major group Chemicals And Allied Products | 347 out of 1,686 | 79th |
Industry group Drugs | 271 out of 1,365 | 80th |
Industry Pharmaceutical Preparations | 221 out of 1,043 | 79th |
Source: SEC filing on April 19, 2016.
Baum's colleagues
We found two more compensation records of executives who worked with Charles M. Baum at Mirati Therapeutics in 2014.